Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 14 | 2020 | 2667 | 1.840 |
Why?
|
| Emergency Medicine | 5 | 2020 | 1014 | 1.800 |
Why?
|
| Advance Care Planning | 4 | 2019 | 432 | 1.720 |
Why?
|
| Emergency Service, Hospital | 17 | 2020 | 6092 | 1.300 |
Why?
|
| Critical Illness | 5 | 2019 | 1980 | 0.890 |
Why?
|
| Hospital Rapid Response Team | 1 | 2020 | 51 | 0.880 |
Why?
|
| Intubation, Intratracheal | 2 | 2018 | 1188 | 0.860 |
Why?
|
| Hospital Mortality | 3 | 2018 | 4455 | 0.850 |
Why?
|
| Emergency Medical Services | 3 | 2019 | 1601 | 0.850 |
Why?
|
| Terminally Ill | 1 | 2020 | 278 | 0.740 |
Why?
|
| Personal Autonomy | 1 | 2018 | 328 | 0.670 |
Why?
|
| Decision Making | 6 | 2020 | 3773 | 0.620 |
Why?
|
| Physicians | 3 | 2020 | 3622 | 0.600 |
Why?
|
| Goals | 1 | 2018 | 555 | 0.590 |
Why?
|
| Terminal Care | 3 | 2020 | 1386 | 0.590 |
Why?
|
| Physician-Patient Relations | 2 | 2019 | 3355 | 0.580 |
Why?
|
| Patient Care Planning | 2 | 2018 | 950 | 0.540 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1043 | 0.540 |
Why?
|
| Patient Preference | 1 | 2019 | 780 | 0.490 |
Why?
|
| Software Design | 1 | 2020 | 195 | 0.420 |
Why?
|
| Patient Participation | 1 | 2018 | 1313 | 0.410 |
Why?
|
| Medical Staff, Hospital | 2 | 2019 | 610 | 0.410 |
Why?
|
| Attitude of Health Personnel | 3 | 2020 | 3849 | 0.390 |
Why?
|
| Mortality | 1 | 2019 | 2517 | 0.380 |
Why?
|
| Referral and Consultation | 4 | 2020 | 3003 | 0.370 |
Why?
|
| Education, Medical, Graduate | 1 | 2018 | 1869 | 0.330 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 331 | 0.330 |
Why?
|
| Workflow | 1 | 2020 | 601 | 0.320 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 55373 | 0.300 |
Why?
|
| Ambulatory Care | 2 | 2019 | 2579 | 0.280 |
Why?
|
| Hepacivirus | 6 | 2006 | 1227 | 0.260 |
Why?
|
| Telemedicine | 2 | 2020 | 1506 | 0.260 |
Why?
|
| Dementia | 1 | 2014 | 1888 | 0.250 |
Why?
|
| Aged | 15 | 2020 | 149815 | 0.240 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2020 | 1045 | 0.240 |
Why?
|
| Emergency Nursing | 1 | 2020 | 42 | 0.230 |
Why?
|
| Risk Assessment | 2 | 2019 | 21779 | 0.230 |
Why?
|
| Mass Screening | 1 | 2016 | 4744 | 0.220 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2006 | 849 | 0.220 |
Why?
|
| Intubation | 1 | 2020 | 136 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2018 | 4673 | 0.220 |
Why?
|
| Maine | 1 | 2019 | 127 | 0.220 |
Why?
|
| Hepatitis C | 6 | 2005 | 1389 | 0.210 |
Why?
|
| Pneumoperitoneum | 1 | 2018 | 42 | 0.200 |
Why?
|
| Resuscitation Orders | 1 | 2020 | 252 | 0.200 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2018 | 44 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2006 | 3574 | 0.190 |
Why?
|
| Health Communication | 1 | 2018 | 200 | 0.160 |
Why?
|
| Humans | 31 | 2020 | 622221 | 0.160 |
Why?
|
| Hospitals, University | 1 | 2017 | 593 | 0.160 |
Why?
|
| Hospitals, Urban | 1 | 2017 | 499 | 0.160 |
Why?
|
| Home Care Services | 1 | 2019 | 466 | 0.160 |
Why?
|
| Area Under Curve | 1 | 2019 | 1654 | 0.150 |
Why?
|
| Program Development | 1 | 2020 | 1311 | 0.140 |
Why?
|
| Video Recording | 1 | 2018 | 920 | 0.140 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 477 | 0.140 |
Why?
|
| Prospective Studies | 4 | 2019 | 44440 | 0.130 |
Why?
|
| Internal Medicine | 1 | 2019 | 938 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2020 | 989 | 0.120 |
Why?
|
| Random Allocation | 1 | 2017 | 2566 | 0.120 |
Why?
|
| ROC Curve | 1 | 2019 | 3317 | 0.120 |
Why?
|
| Male | 13 | 2019 | 331025 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 983 | 0.120 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3309 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2018 | 991 | 0.120 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3356 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2653 | 0.120 |
Why?
|
| Female | 13 | 2019 | 349886 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 26493 | 0.110 |
Why?
|
| Clinical Audit | 1 | 2019 | 25 | 0.110 |
Why?
|
| Quality of Life | 1 | 2019 | 8941 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2018 | 4346 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2018 | 7114 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 15120 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2020 | 2446 | 0.100 |
Why?
|
| Health Services Research | 1 | 2016 | 1833 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2019 | 35507 | 0.100 |
Why?
|
| New York | 1 | 2020 | 761 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2020 | 2739 | 0.090 |
Why?
|
| Forecasting | 1 | 2017 | 2832 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2018 | 8488 | 0.090 |
Why?
|
| Nurse's Role | 1 | 2019 | 177 | 0.090 |
Why?
|
| Communication | 1 | 2020 | 2848 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2018 | 2714 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 5091 | 0.090 |
Why?
|
| Internet | 1 | 2020 | 3040 | 0.090 |
Why?
|
| Inpatients | 1 | 2016 | 1637 | 0.090 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2005 | 237 | 0.090 |
Why?
|
| Feedback | 1 | 2019 | 683 | 0.080 |
Why?
|
| Critical Care | 1 | 2018 | 2099 | 0.080 |
Why?
|
| HLA-B8 Antigen | 1 | 2004 | 20 | 0.080 |
Why?
|
| Telephone | 1 | 2019 | 586 | 0.080 |
Why?
|
| Immunodominant Epitopes | 1 | 2005 | 262 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2018 | 56229 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 1373 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12925 | 0.070 |
Why?
|
| Health Services | 1 | 2019 | 682 | 0.070 |
Why?
|
| Massachusetts | 1 | 2017 | 8337 | 0.070 |
Why?
|
| Hospitalization | 2 | 2019 | 7638 | 0.070 |
Why?
|
| Hospitals | 1 | 2016 | 2367 | 0.070 |
Why?
|
| Survival Rate | 1 | 2018 | 12699 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2018 | 3096 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2018 | 4023 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 14659 | 0.060 |
Why?
|
| Heart Failure | 2 | 2019 | 7871 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2005 | 954 | 0.050 |
Why?
|
| Caregivers | 1 | 2019 | 1300 | 0.050 |
Why?
|
| Models, Biological | 1 | 2017 | 10231 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2014 | 3183 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 1660 | 0.050 |
Why?
|
| Hepatitis C, Chronic | 1 | 2006 | 926 | 0.050 |
Why?
|
| Algorithms | 1 | 2018 | 12676 | 0.050 |
Why?
|
| Hospitals, Community | 1 | 2019 | 299 | 0.050 |
Why?
|
| Middle Aged | 5 | 2018 | 203146 | 0.050 |
Why?
|
| Cost Control | 1 | 2019 | 626 | 0.050 |
Why?
|
| Acute Disease | 3 | 2019 | 7086 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 4924 | 0.040 |
Why?
|
| Policy | 1 | 2016 | 136 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 2188 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2016 | 487 | 0.040 |
Why?
|
| Remission, Spontaneous | 2 | 2005 | 411 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 1519 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2020 | 4253 | 0.040 |
Why?
|
| Pandemics | 2 | 2020 | 3742 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2005 | 2362 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 13680 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2018 | 646 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 8530 | 0.030 |
Why?
|
| Viremia | 2 | 2005 | 640 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 18184 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1137 | 0.030 |
Why?
|
| United States | 3 | 2019 | 58511 | 0.030 |
Why?
|
| Adult | 4 | 2018 | 197768 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 64305 | 0.030 |
Why?
|
| Consensus | 1 | 2016 | 1698 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2569 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 2005 | 5883 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1412 | 0.020 |
Why?
|
| HIV-1 | 1 | 2004 | 6496 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2019 | 2519 | 0.020 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2005 | 88 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2005 | 1990 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 3273 | 0.020 |
Why?
|
| Mutation | 2 | 2006 | 26892 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 2005 | 710 | 0.020 |
Why?
|
| Ribavirin | 1 | 2005 | 397 | 0.020 |
Why?
|
| Hepatitis C Antigens | 1 | 2002 | 33 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 2442 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2004 | 820 | 0.020 |
Why?
|
| HLA-A2 Antigen | 1 | 2002 | 237 | 0.020 |
Why?
|
| Cell Count | 1 | 2006 | 1999 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2005 | 892 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2006 | 876 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7226 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 1584 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2005 | 1179 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 1876 | 0.010 |
Why?
|
| Prevalence | 1 | 2016 | 13804 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2004 | 1617 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 2555 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 18574 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 2610 | 0.010 |
Why?
|
| Viral Load | 1 | 2004 | 2863 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 4370 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1907 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6425 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 7115 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 4140 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 4056 | 0.010 |
Why?
|
| Biopsy | 1 | 2004 | 6450 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 14896 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 20037 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 7456 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 6768 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 12726 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5036 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2004 | 6264 | 0.010 |
Why?
|
| Neoplasms | 1 | 2016 | 17009 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 20874 | 0.010 |
Why?
|
| HIV Infections | 1 | 2004 | 13978 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 167159 | 0.000 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_